CEO

Lisa Graver

Lisa Graver serves as the CEO for Alvogen and its affiliate Almaject. She has worked in various leadership roles in the pharmaceutical industry for the past 20 years. Her background in patent and regulatory strategy has been integral to Alvogen’s success. Under Lisa’s leadership, Alvogen is actively pursuing the expansion of its US product portfolio through development and acquisition of products.

Lisa holds her Juris Doctorate from Case Western University School of Law and an Honors Bachelor of Science degree from Lakehead University.